Related Experiment Video
Updated: Aug 14, 2026

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
Abstract:
Although acetylsalicylic acid (aspirin) can cause acute damage to human gastric mucosa, its relationship to chronic gastric ulcer has been less documented. A study of the aspirin intake of 61 patients with gastric ulcer revealed that 32 (52%) took 15 or more aspirins each week, compared to 6 (10%) age- and sex-matched controls who took such amounts (P less than 0.001). This difference remained significant when patients who took aspirin for relief of alimentary symptoms or when patients whose symptoms preceded aspirin use were excluded. The regular use of aspirin was especially associated with ulcers in the prepyloric region of the stomach. Fewer patients who had combined gastric and duodenal ulcers were regular users of aspirin when compared with patients who had gastric ulcer alone. The findings suggest that aspirin may be a common cause of gastric ulcer in man.
More Related Videos
08:56Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions
Published on: November 30, 2022
03:05Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia
Published on: February 16, 2024
Related Concept Videos
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
However, this neutralization reaction between...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...